Olysio
Oct. 5, 2024
Olysio Fact Sheet Олисио (Olysio) - симепревир OLYSIO® (simeprevir) Gains Additional FDA Approval as Once-Daily, All-Oral Interferon- and Ribavirin-Free Treatment Option in Combination with Sofosbuvir for Adults with Genotype 1 Chronic Hepatitis C Infection FDA Expands Olysio for Combo Use in Hepatitis C Infection - MPR Olysio: further oral treatment option for chronic hepatitis C Daily Medication Pearl: Simeprevir (Olysio) | Olysio
